Event Location
Date: 12th June 2018 - 12th September 2018Location: BioCeuticals Head Office Unit 1/ Level 1, 85 O'Riordan St ALEXANDRIA NSW Australia 2015
Event Details
Dr Leila Masson
Dr Leila Masson, Consultant Pediatrician, AIMA Board member will be providing updates on the AIMA Integrative Medicine Pathway and the AIMA Interprofessional Communications Working Group.
Dr Denise Furness
Nutrigenomics and detoxification workshop - Identifying risk and susceptibility for chemical and toxin sensitivities
In today’s world, it’s impossible to escape the impact of environmental toxins. They are in the air we breathe, the water we drink, the food we eat, in our homes and our workplaces. While our bodies are normally very efficient at dealing with a considerable toxic load, we do have our limits.
It’s important to recognise that the ability to detoxify varies from person to person, depending on the genes they inherit. We know that certain gene variants, often referred to as SNPs (single nucleotide polymorphisms), can affect detoxification enzymes and pathways, compromising our ability to effectively process and remove a wide range of compounds.
This event with Dr Denise Furness explores the key genes associated with detoxification, including phase 1 (CYP 450 enzymes) and phase 2 pathways, as well as genes responsible for endogenous antioxidant systems.
Date: Tuesday 12 June 2018
Program
6:30pm Arrival, registration & light dinner
7:00pm Start
8:30pm Q&A
9:00pm Event concludes
AIMA Meetup & Nutrigenomics and detoxification workshop Tuesday 12 June 2018
Time: 6:30pm - 9:00pm
Learning objectives:
- Recognise the daily exposures to chemicals and toxins which can compromise your patients’ health.
- Understand the role toxins can play in the development of conditions such as autoimmunity, cancer, infertility, pregnancy complications and mental health disorders.
- Identify factors, including genetic variants, which increase a patient’s sensitivity to specific toxins in the environment.
- Review the pathways of detoxification, key endogenous antioxidant enzymes and genetic variations which can impact normal functioning of these.
- Discuss case studies where DNA testing in combination with other investigations has been utilised to support establishment of a suitable treatment strategy.
Our Speakers
Ref: #1714840210-3